ADGRD1 and neoplasm: To further investigate the effects of GPR133 on tumorigenicity in vivo, we subcutaneously injected A549 cells with increasing GPR133 expression into nude mice and assessed the subsequent tumor growth; ultimately, the results showed that overexpression of GPR133 could markedly suppress tumor growth in vivo (Fig. 5B).